Le Lézard
Classified in: Science and technology, Covid-19 virus
Subject: Product/Service

Lumeon Eases the Burden on Care Teams with the Rapid Deployment of COVID-19 Vaccination Self-Scheduling


Lumeon, the leader in care journey orchestration, today announced the launch of its COVID-19 Vaccination Campaign Management solution, allowing healthcare providers to rapidly deploy vaccination programs and alleviate the pressure on care teams with automated patient outreach, self-scheduling, and surveys.

Administering the COVID-19 vaccine to the general public is expected to create an incredibly complex logistical challenge for health systems. Achieving herd immunity requires an estimated 50 to 80 percent of a population to be vaccinated ? in the United States, this would mean vaccinating between 164 million and 226 million citizens. Care teams will be tasked with juggling an immense load of scheduling patients, preparing and counseling them, making sure they turn up to their appointments, and providing care to those experiencing adverse side-effects.

Based on Lumeon's proven flu and population screening solutions, the COVID-19 Vaccination Campaign Management solution alleviates this burden by orchestrating the vaccine scheduling process. It enables healthcare workers to contact patients at scale via email or SMS, providing a link for patients to self-schedule their appointments at their preferred clinic. Once patients select their preferred appointment slots, Lumeon's solution then synchronizes these slots with the provider's own scheduling system and continues to educate and engage the patient to reduce no-shows, instruct the patient about arrival logistics, what to expect, and monitor them for adverse effects.

The solution is simple to use and fast to deploy, with phased deployment requiring zero integration at the outset with providers' existing scheduling tools or the EHR.

"Healthcare systems across the world are coming upon an unprecedented logistical challenge that will overwhelm them if they don't have the correct processes in place," said Robbie Hughes, Lumeon CEO. "Orchestrating as much of vaccine demand management and scheduling process as possible will be key to ensuring patients are vaccinated quickly and seamlessly, while reducing the burden on care teams so that they can continue to focus on their most critical patients and tasks. Our platform can be deployed with zero integration so providers can get up and running with the solution immediately, especially now that the vaccine's distribution is picking up speed."

Hughes continued, "The potential of orchestration in administering vaccines reaches far beyond COVID-19. From flu shots to tetanus boosters and other required screenings, having the ability to create more efficient care processes through care journey orchestration will be a boon for healthcare provider revenue for decades to come."

Learn more about Lumeon's COVID-19 solutions here.

About Lumeon

Lumeon's care journey orchestration platform helps health systems scale efficient, effective care delivery both within and beyond their hospitals' four walls.

Lumeon's industry-leading solutions address the needs of patient access, surgery, population health, amongst many others. They transform the EHR into an agile care delivery platform that navigates the patient along a personalized, adaptive care plan, coordinating the care team to deliver the right care, at the right time, every time. At every step along the journey, they harmonize care, communication, tasks, and decisions to increase compliance and productivity, free up capacity, and deliver superior outcomes at a reduced cost.

More than 70 health systems across 12 countries have deployed Lumeon's multi-award-winning platform. www.lumeon.com


These press releases may also interest you

at 07:35
Griffon Corporation ("Griffon" or the "Company") today reported results for the fiscal 2024 second quarter ended March 31, 2024. Revenue for the second quarter totaled $672.9 million, a 5% decrease compared to $711.0 million in the prior year...

at 07:30
ELSE NUTRITION HOLDINGS INC. (BABY) (BABYF) (0YL.F) ("Else" or the "Company"), is proud to announce that it has expanded its product listings at one of the largest independent food retailers in the United States, which ranks 5th among the largest...

at 07:30
U.S. Gold Corp. ("U.S. Gold," the "Company," "we," "our" or "us") , today announced that its wholly owned subsidiary, Gold King Corp., has been issued its Surface Gold Mine Permit, dated April 29, 2024 (the "Mine Operating Permit"), from the Director...

at 07:30
Mastech Digital, Inc. , a leading provider of Digital Transformation IT Services, announced today its financial results for the first quarter ended March 31, 2024.   First Quarter 2024 Highlights: Total consolidated revenues declined by 15% to $46.8...

at 07:30
Karyopharm Therapeutics Inc. , a commercial-stage pharmaceutical company pioneering novel cancer therapies, announced today that it has...

at 07:30
? Announces Significant Refinancing Transactions and Amends Royalty Agreement with HealthCare Royalty Extending Vast Majority of Its Debt Maturities into 2028 and 2029, Well Beyond Expected Data Readouts and Potential Approvals from the Company's...



News published on and distributed by: